← Evidence map

ArticleCancer medicine2021

Phase 1 study of telisotuzumab vedotin in Japanese patients with advanced solid tumors.

Yutaka Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

9 papers cite it

2021
2022
2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 33675179